Relevant conflicts of interest/financial disclosures: Belinda Kessel has been to sponsored meetings by Teva Pharmaceuticals Ltd. Full financial disclosures and author roles can be found in the online version of this article.
Letter to the Editor
Rasagiline-induced serotonin syndrome†
Version of Record online: 2 MAR 2011
Copyright © 2011 Movement Disorder Society
Volume 26, Issue 4, pages 766–767, March 2011
How to Cite
Fernandes, C., Reddy, P. and Kessel, B. (2011), Rasagiline-induced serotonin syndrome. Mov. Disord., 26: 766–767. doi: 10.1002/mds.23649
- Issue online: 19 APR 2011
- Version of Record online: 2 MAR 2011
- Manuscript Accepted: 29 DEC 2010
- Manuscript Revised: 24 DEC 2010
- Manuscript Received: 5 AUG 2010
|MDS_23649_sm_authorroles.doc||20K||Author Roles and Disclosures|
Please note: Wiley Blackwell is not responsible for the content or functionality of any supporting information supplied by the authors. Any queries (other than missing content) should be directed to the corresponding author for the article.